Company Filing History:
Years Active: 2022
Title: Samia Naccache: Innovator in Pathogen Detection
Introduction
Samia Naccache is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of pathogen detection through her innovative work in next-generation sequencing technologies. With a total of 2 patents, her research is paving the way for advancements in medical diagnostics.
Latest Patents
Naccache's latest patents focus on systems and methods for pathogen detection using next-generation sequencing (NGS) analysis. These embodiments utilize alignment algorithms, such as SNAP and RAPSearch, to align individual sequence reads from a sample against reference genome entries in a classified reference genome database. The invention includes features for classifying, filtering, and displaying results to clinicians, enabling them to quickly identify pathogens or other genetic material in tested samples. By employing a negative sample and a corresponding database, the system effectively removes contaminants from the list of candidate pathogens, streamlining the identification process.
Career Highlights
Samia Naccache is affiliated with the University of California, where she continues to advance her research in pathogen detection. Her work has garnered attention for its potential impact on public health and disease management.
Collaborations
Naccache collaborates with notable colleagues, including Charles Chiu and Scot Federman, who contribute to her research endeavors and enhance the scope of her work.
Conclusion
Samia Naccache's innovative contributions to pathogen detection through next-generation sequencing exemplify her commitment to advancing medical diagnostics. Her work not only enhances the understanding of pathogens but also improves the efficiency of identifying them in clinical settings.